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Loss-of-function mutations in GLI3 and IHH cause craniosynostosis and reduced
osteogenesis, respectively. In this study, we show that Ihh ligand, the receptor Ptch1
and Gli transcription factors are differentially expressed in embryonic mouse calvaria
osteogenic condensations. We show that in both Ihh−/− and Gli3Xt−J/Xt−J embryonic
mice, the normal gene expression architecture is lost and this results in disorganized
calvarial bone development. RUNX2 is a master regulatory transcription factor controlling
osteogenesis. In the absence of Gli3, RUNX2 isoform II and IHH are upregulated, and
RUNX2 isoform I downregulated. This is consistent with the expanded and aberrant
osteogenesis observed in Gli3Xt−J/Xt−J mice, and consistent with Runx2-I expression
by relatively immature osteoprogenitors. Ihh−/− mice exhibited small calvarial bones and
HH target genes, Ptch1 and Gli1, were absent. This indicates that IHH is the functional
HH ligand, and that it is not compensated by another HH ligand. To decipher the roles
and potential interaction of Gli3 and Ihh, we generated Ihh−/−;Gli3Xt−J/Xt−J compound
mutant mice. Even in the absence of Ihh, Gli3 deletion was sufficient to induce aberrant
precocious ossification across the developing suture, indicating that the craniosynostosis
phenotype of Gli3Xt−J/Xt−J mice is not dependent on IHH ligand. Also, we found that
Ihh was not required for Runx2 expression as the expression of RUNX2 target genes
was unaffected by deletion of Ihh. To test whether RUNX2 has a role upstream of IHH,
we performed RUNX2 siRNA knock down experiments in WT calvarial osteoblasts and
explants and found that Ihh expression is suppressed. Our results show that IHH is
the functional HH ligand in the embryonic mouse calvaria osteogenic condensations,
where it regulates the progression of osteoblastic differentiation. As GLI3 represses the
expression ofRunx2-II and Ihh, and also elevates theRunx2-I expression, and as IHHmay
be regulated by RUNX2 these results raise the possibility of a regulatory feedback circuit
to control calvarial osteogenesis and suture patency. Taken together, RUNX2-controlled
osteoblastic cell fate is regulated by IHH through concomitant inhibition of GLI3-repressor
formation and activation of downstream targets.
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INTRODUCTION
The majority of the bones of the face and calvaria are formed
by intramembranous ossification. Growth occurs primarily at
the bone edges in the sutural joints (Rice and Rice, 2008).
We and others have shown that across the suture there is the
complete spectrum of osteogenic differentiation from quiescent
stem cells through all osteoprogenitor stages to functioning
mature osteoblasts. The expansion of each cell population is
tightly regulated and dependent on the functional demands
of the growing skull (Lana-Elola et al., 2007; Zhao et al.,
2015; Maruyama et al., 2016). Osteoprogenitors condense at
the osteogenic fronts and in order for osteogenesis to proceed
a constant supply of progenitor cells must be available (Rice
et al., 2003; Lana-Elola et al., 2007). Mis-regulation of the
osteogenic condensations will result in alterations in skull
bone shape and size, as well as in the patency of the
sutures with consequent effects on skull growth. Within this
niche, GLI transcription factors regulate stem cell maintenance,
osteoprogenitor proliferation and differentiation (Rice et al.,
2010; Veistinen et al., 2012). GLI1-positive cells in the suture
mesenchyme are a source of mesenchymal stem cells, and
ablation of Gli1 in postnatal mice results in the premature
fusion, or craniosynostosis, of all the calvarial sutures and the
consequent secession of growth (Zhao et al., 2015). GLI3 loss
of function mutations cause craniosynostosis resulting in fusion
across the interfrontal suture in patients and across the lambdoid
and interfrontal sutures in mice (McDonald-McGinn et al.,
2010; Rice et al., 2010; Hurst et al., 2011). These differences
in phenotypes can, in part, be explained by location-specific
differences in mRNA expression. Gli1 is expressed evenly in all
calvarial sutures while Gli3 transcripts are more highly expressed
in the interfrontal and lambdoid sutures compared to other
calvarial sutures (Rice et al., 2010; Zhao et al., 2015).
GLI proteins are regulators of Hedgehog (HH) signaling, with
GLI3 mainly functioning as a repressor of HH target genes. In
the absence of the HH ligand GLI3 is proteolytically cleaved into
the truncated repressor isoform, GLI3R (Wang et al., 2000). GLI3
acts as a strong repressor during limb patterning and during
endochondral ossification, with SHH regulating limb patterning
and IHH regulating cartilage development (Litingtung et al.,
2002; Hilton et al., 2005; Koziel et al., 2005).
Indian hedgehog (Ihh) is expressed in the embryonic calvaria,
and in osteoblastic cells has been shown to upregulate an
osteogenic master regulator Runx2 through GLI2 activator
function (GLI2A) (Shimoyama et al., 2007; Rice et al., 2010). It
has been proposed that IHH regulates several stages of osteoblast
differentiation, either through Gli3R or Gli2A functions (Hilton
et al., 2005; Joeng and Long, 2009). Although IHH is essential
for osteoblast differentiation during endochondral ossification,
it is not essential for intramembranous bone development.
Osteoblasts appear to develop normally in calvarial bones of
Ihh−/− mice although the bones are reduced in size (St-Jacques
et al., 1999; Lenton et al., 2011). By mapping the gene expression
of Ihh in the developing chick dentary bone and analyzing
the retroviral missexpression (gain of function) of Ihh in the
developing chick frontal bone, it has been proposed that IHH
regulates the transition of osteoprogenitors to osteoblasts. It is
suggested that IHH does this by restricting the differentiation
of preosteoblasts so that they can proliferate for longer which
increases the pool of progenitors (Abzhanov et al., 2007). There
is also evidence that IHH positively regulates osteoprogenitor
recruitment to the osteogenic front possibly by controlling Bone
morphogenetic protein (BMP) signaling (Lenton et al., 2011).
We have shown earlier how Gli3Xt−J/Xt−J mice, which
produce no functional GLI3 protein, can be used as a model to
study craniosynostosis and suture biogenesis, and by genetically
reducing the dosage of Runx2 the calvarial phenotype can be
rescued (Rice et al., 2010; Tanimoto et al., 2012; Veistinen
et al., 2012). The transcription factor TWIST1 negatively
regulates osteogenesis by inhibiting Runx2 through direct DNA
binding (Rice et al., 2000, 2010; Bialek et al., 2004), and in
Gli3Xt−J/Xt−J mice the expression of Twist1 is reduced across the
sutures. This aberrant signaling results in an increased pool of
osteoprogenitors and enhanced osteogenic differentiation, with
consequent ectopic bone formation and suture fusion. Support
for this mechanism comes from premature activation of Runx2
in embryonic day (E) 9.5 mice, as well as from the deletion of
one allele of Twist1 both of which result in enhanced osteogenesis
and craniosynostosis (Bourgeois et al., 1998; Maeno et al., 2011).
GLI3 repressor reduces RUNX2 activity by competing for the
sameDNA target sequences, thus negatively regulating osteoblast
differentiation (Ohba et al., 2008; Lopez-Rios et al., 2012).
In this study we aimed to elucidate whether GLI3 controls
IHH regulated intramembranous osteogenesis, and to test
whether IHH, GLI3 and RUNX2 regulate and maintain the
different stages of osteogenesis within the patent suture.
We show that IHH is the functional HH ligand in the
embryonic mouse calvaria osteogenic condensations, where it
regulates the progression of osteoblastic differentiation. We also
demonstrate a location specific regulatory role for GLI3 repressor
within the suture which is independent of IHH expression,
as Ihh deletion does not rescue craniosynostosis exhibited by
Gli3Xt−J/Xt−J mice. In addition, we show that GLI3 represses the
expression of Runx2-II and Ihh, and elevates Runx2-I. And that
IHH is regulated by RUNX2 in calvarial osteoblasts. These data
raise the possibility of a regulatory feedback circuit to control
calvarial osteogenesis and suture patency.
MATERIAL AND METHODS
Mice
The Ihh+/− andGli3+/Xt−Jmicemaintenance, breeding and PCR
genotyping has been described previously (Koziel et al., 2005).
Wild-type (WT) littermates NMRI mice were used as controls.
All animal experiments were approved by the University of
Helsinki, Helsinki University Hospital and the Southern Finland
Council Animal Welfare and Ethics committees.
In Situ Hybridization
E13.5 and E15.5 tissues were fixed in a copious volume of freshly
prepared 4% paraformaldehyde overnight at 4◦C. They were
then washed in PBS before dehydrating in an increasing strength
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ethanol or methanol series before in situ hybridization on either
tissue sections or whole mounts, respectively.
Ihh, Ptch1, Gli1-3, Runx2, Osx, Bglap, and Ibsp riboprobes
were prepared, and in situ hybridization was performed as
described previously and briefly described below (Rice et al.,
2006; Tanimoto et al., 2012).
In Situ Hybridization on Tissue Sections
Sections (7µm) were deparaffinised, rehydrated and
permeabilized with proteinase K. Tissues were hybridized
overnight at 52◦C with 35S-UTP labeled riboprobes.
Hybridization was followed by high stringency washes at
50◦C and at 65◦C. Slides were then washed in NTE at 37◦ and
treated with ribonuclease A to remove non-specifically bound
and excess probe. The slides were coated with autoradiography
liquid emulsion and exposed in a dark box for 10–18 days at 4◦C.
The slides were developed, fixed and then counterstained with
hematoxylin.
In Situ Hybridization on Whole Mounts
Samples were rehydrated, bleached withH2O2 and permeabilized
with proteinase K. Tissues were prehybridized in PBST. Tissues
were hybridized overnight at 64◦C with denatured digoxigenin-
labeled probes followed by high stringency washes. Next tissues
were washed MABT then pre-blocked at room temperature for
3 h prior to overnight incubation with anti-dig-antibody coupled
to alkaline phosphatase 4◦C. Following extensive MABT and
NTMTwashes the color reactionwas performedwithNBT/BCIP.
Immunohistochemistry
Immunohistochemical staining was performed as described
previously (Rice et al., 2016). Briefly tissue sections were
permeabilized and blocked, then incubated overnight at 4◦C
with anti-IHH (AF1705, R&D systems), anti-GLI1 (L42B10,
Cell Signaling), anti-GLI3 (AF3690, R&D systems) or anti-
PTCH1(G-19, Santa Cruz Biotechnology). Signal visualization
was performed using Enzmet HRP detection (Nanoprobes).
Sections were counterstained with nuclear fast red.
Skeletal Staining
Heads of mutant mice and WT littermates aged E16.5 and
E18.5 were fixed in 95% ethanol overnight and stained with
Alcian blue and Alizarin red and then cleared in 1% KOH and
transferred to glycerol. For calculations of calvarial bone and
suture size, images were captured using AnalySIS software (Soft
Imaging System) and Olympus BX41 microscope and analyzed
in Adobe R© Photoshop CS4.
Western Blot Analysis
Calvaria were dissected from E15.5 WT embryos and tissue
samples taken from osteogenic front of the frontal bone and
from interfrontal midsutural mesenchyme. Samples were pooled
from three calvaria of the same litter and this was repeated 4
times. Age-matched brain tissue was used as control. Western
blotting was carried out as described previously (Tanimoto
et al., 2012). Briefly, 10 µg of each sample was probed for
GLI3 antibody (AF3690, R&D Systems), GLI1 antibody (2643,
Cell Signaling Technology), α-tubulin (T6199, Sigma-Aldrich).
20 µg of total protein from siRNA treated calvarial cells was
probed for RUNX2 antibody (8486, Cell Signaling Technology),
IHH antibody (AF1705, R&D Systems), and normalized against
signal by Actin antibody (A2066 Sigma), detected by secondary
antibodies goat anti-mouse IRDye 800CW (926-32210, LI-
COR) and goat anti-rabbit 680RD (926-68071, LI-COR). Blots
were analyzed with an Odyssey CLx infrared imager (model
9120) (Li-Cor) and Image-J (NIH) software. Statistical values
were calculated using Student’s t-test, with P-value below 0.05
indicated as significant.
The Effect of Exogenous IHH on Primary
Calvaria Derived Cells
Mouse E15.5 wild type (WT) primary calvaria derived cells
(CDC) were isolated by trysinization and cultured for several
days in DMEM containing high glucose and supplemented
with 10% FBS. Cells were pooled from at least 2 calvaria.
After 1st passage cells were seeded onto 6-well plates for
experiments (100,000 cells per well). After 48 h of culture,
cells were treated with recombinant human/mouse IHH protein
(1705-HH-025 R&D systems): 50, 100, 250 ng/ml, and control
cells with BSA (bovine serum albumin) for 1, 2, 6, and 24 h.
RNA isolated from control and IHH treated CDC cells was
quantified. 300 ng of RNA was used for cDNA synthesis using
reverse transcriptase enzyme and random hexamer primers.
Thereafter, RT-qPCR was performed using the primers Gli1
(FP:CAGCATGGGAACAGAAGGACT, RP:CTCTGGCTGCTC
CATAACCC), Gli2 (FP:AACTTTTGTCTCCTCGGGTCC,RP:
CTGCTGTCCTCCAAGAGACC) and Gli3 (FP:AAGCCCATG
ACATCTCAGCC,RP:CTCGAGCCCACTGTTGGAAT). SYBR
fast (Kapa Biosystems) qPCR master mix was used for real
time quantitative PCR using Quant studio 3 from Thermo
scientific. Mouse 18S rRNA gene was used as the reference
gene and negative control with no cDNA was used. The
experiment conducted 3 times, each time with different biological
samples.
Calvarial Osteoblasts and Explant Cultures
E15.5 mouse calvarial cells were isolated by four sequential
trypsin-treatments of whole calvaria separated from the skin
and meninges. The first set of cells after 15min 0.25% trypsin
incubation were discarded, and the cells from the following
trypsin treatments were pooled and cultured in growth medium
(DMEM containing 4,5 g/L glucose supplemented with 1mM
Na-pyruvate, 4mM L-glutamine, 1% penicillin-streptomycine,
and 10% FBS, (Lonza and Gibco).
Analysis of Wt and Gli3Xt−J/Xt−J calvarial cells: At passage
2 the cells were transferred into new growth medium until
confluent from which cell lysates were derived. Western blot
analyses were carried out with 20 µg of total protein.
siRNA experiments: At passage 2 the cells were transfected
either with negative control siRNA (Ambion Silencer Select
control #1 siRNA, 4390843, Thermo Fisher) or Runx2 siRNAs
(Ambion 4390771 Runx2 Silencer Select Pre-designed siRNA,
Thermo Fisher) using Lipofectamine RNAiMAX (Thermo
Fisher). Cells were grown on six well plates with the siRNA
transfection complex for 3 days, after which the medium
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was replaced by osteogenic medium (DMEM, 10mM β-
glycerophosphate, (Sigma), 50µg/ml ascorbic acid, Sigma, and
100 ng/ml BMP2 (R&D Systems) for 24 h from which cell lysates
were derived. Western blot analyses were carried out with 20 µg
of total protein. siRNA experiments were carried out 3 times.
E15 mouse calvarias were dissected for Trowell type of
organ culture (Rice et al., 2000). Affi-gel agarose beads (Bio-
Rad) were washed with PBS, and circa 200 beads were
soaked with premixed siRNA—RNAiMAX reagent (Thermo
Fisher) at 37◦C for 30min. Several beads were placed on the
calvarias that were further cultured for 3 days in osteogenic
medium. Efforts were made to place beads onto comparable
areas of the calvaria that had endogenous expression of
either Runx2 full length or Ihh (Rice et al., 2010). The
areas of Ihh expression in WT E15.5 calvaria were further
identified (Figure 1B) and beads impregnated with either
negative control or anti-RUNX2 SiRNAs were placed on the
parietal bone osteogenic fronts for IHH experiments, which can
be identified in bright field microscopy (Kim et al., 1998). Beads
placed on the parietal bone or osteogenic fronts for RUNX2
experiments.
RESULTS
Location Specific Regulatory Role of GLI3
Repressor
To determine the specific transcript (Figures 1A–C) and
protein (Figure 1D) expression domains and protein activity
of HH pathway members in the developing calvaria in situ
hybridization and immunohistochemistry were performed.
Detailed in situ hybridization was performed at different
developmental stages of calvarial and suture maturation. In
an attempt to get comparable data, at both E13.5 and
E15.5 analysis was done on consecutive E15.5 calvarial tissue
sections. Also, at E15.5 whole calvarial tissue was analyzed
to determine whether all sutures have similar expression
patterns.
Ihh mRNA and protein were detected in the osteogenic
fronts of all the calvarial bones, in a very restricted group of
osteoprogenitors (Figures 1C,D). In addition there was weak
protein expression across the suture. The cell surface HH
receptor Ptch1 and Gli1 and Gli2 expression domains were
overlapping with that of Ihh. Ptch1 and Gli1 are induced by HH
ligand and therefore indicate the limit of Hedgehog activation
(Lee et al., 2016). In contrast, Gli3 was diffusely expressed across
the sutural mesenchyme.
In general, the calvarial osteogenic fronts (E15.5) have similar
expression patterns to the osteogenic condensations (E13.5).
Indeed, the osteogenic fronts can be considered analogous to
osteogenic condensations with similar steps and regulation of
osteoblastic differentiation and development. We also observe
a differential expression of Gli3 in different sutures which may,
in part, explain the suture specific phenotype seen in mice and
patients with GLI3mutations.
To establish if GLI3R is the predominant protein isoform in
the calvarial suture, we performed western blotting on tissue
samples dissected from either the midsuture or the osteogenic
front from WT calvaria (Figure 1E). The total amount of GLI3
protein was higher in the midsutural samples. Both isoforms
were observed in both samples, but the level of GLI3R was
higher in the suture compared to the osteogenic front, and the
opposite was true for the GLI3FL (Full length) (Figures 1F,G).
The ratio of GLI3R/GLI3FL was significantly higher in the
suture mesenchyme indicating that GLI3R is predominate in the
midsutural tissue.
To verify whether a sample was midsutural or from the
osteogenic front, we blotted the samples against GLI1. GLI1
also acts as a read-out for HH signaling, and based on our
in situ hybridization results, HH signaling is active only in the
osteogenic front. The level of GLI1 protein was significantly
higher in the osteogenic front samples compared to the samples
isolated from the suture (Figures 1F,G). Taken together, HH
signaling is activated in the osteogenic fronts and GLI3R is
predominantly localized in the midsutural mesenchyme.
GLI3 Represses the Expression of Runx2-II
and Ihh, and Elevates Runx2-I
RUNX2-I and RUNX2-II isoforms differ in their N-termini
due to alternative promoter usage which results in dissimilar
functions during bone development (Fujiwara et al., 1999; Zhang
et al., 2009). Across developing sutures, Runx2 isoforms are
differentially expressed with Runx2-I primarily expressed in
relatively undifferentiated osteoprogenitors and Runx2-II in cells
further along in osteoblastic differentiation (Park et al., 2001).We
have previously shown that Runx2 is ectopically expressed across
the Gli3Xt−J/Xt−J suture (Rice et al., 2010). Here we analyzed
their protein levels in osteogenic cells isolated from Gli3Xt−J/Xt−J
calvaria. We found that RUNX2-II was upregulated and RUNX2-
I downregulated, compared to wild type controls indicating that
inGli3Xt−J/Xt−J mice the osteoprogenitors within the suture were
more differentiated than their WT littermates (Figures 2B,C).
These results indicate that GLI3 maintains osteoprogenitors in
an undifferentiated state by participating in the regulation of
RUNX2. These data help explain the location specific differences
seen in mRNA expression in Gli3Xt−J/Xt−J calvaria and the
craniosynostosis observed.
As Runx2 expression is altered in Gli3Xt−J/Xt−J calvaria
(Figure 2) (Rice et al., 2010), and RUNX2 is known to regulate
limb growth through the induction of Ihh (Yoshida et al., 2004),
we analyzed IHH protein levels in Gli3Xt−J/Xt−J cells. We found
IHH to be upregulated (Figure 2D). This indicates that the lack
of GLI3 has allowed either increased IHH expression or a broader
IHH protein expression domain.
Ihh Does Not Alter the Expression of Gli3
mRNA
Inmesenchymal cells of the developing limb bud, Sonic hedgehog
is known to up-regulate Gli transcription, while down-regulating
Gli3 expression (Marigo et al., 1996). To test whether IHH
has a direct effect on the expression of Gli3 in WT primary
calvaria derived cells (CDC) we added recombinant mouse IHH,
of varying concentration, to mouse E15.5 calvarial cells and
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FIGURE 1 | Regulatory role for GLI3R suggested by location-specific expression. (A–C) mRNA and protein expression (D) of hedgehog ligand, receptor and
transcription factors in consecutive paracoronal calvarial tissue sections in E13.5 and E15.5 WT mice (black arrows). Ihh is expressed by a narrow strip of cells in the
(Continued)
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FIGURE 1 | osteogenic fronts calvarial bone primordia. Ptch1, Gli1,-2 and−3 are also expressed in the osteogenic fronts but in a wider domain than Ihh. Gli3 is also
expressed more distant from the osteogenic fronts in the midsutural mesenchyme (white arrows). (E) Schematic to show the areas of tissue sampling from E15.5 WT
calvaria interfrontal midsutural mesenchyme (green) and osteogenic fronts of frontal bones (red). (F)Western blot analysis (triplicate), GLI3R (83 kDa) is the upper band
indicated by the arrowhead. Integrated density values obtained for GLI3; both GLI3 full-length (GLI3FL) (190 kDa) and GLI3R, and GLI1 levels were normalized against
those of α-tubulin and compared against the samples (G). GLI3R/GLI3FL ratio is higher in the midsutural mesenchyme compared to the osteogenic front. Conversely,
normalized GLI1 intensity is greater in the osteogenic fronts compared to the midsuture. Error bars standard deviation. Statistical values calculated using Student’s
t-test, with p < 0.05 considered significant (*p < 0.05). b, brain; e, eye; f, frontal bone; if, interfrontal suture, ip, interparietal bone; l, lambdoid suture; p, parietal bone;
s, sagittal suture; sut mes, sutural mesenchyme. Scale bars: (A–C) 250µm, (D) 100µm.
investigated Gli1, −2 and −3 expression levels RT-qPCR at
different time points.
Exogenous IHH did not alter the mRNA levels of Gli3
or Gli2 (Supplementary Figure 1). At 24 h, IHH exposure
resulted in a gradual up-regulation of Gli1 expression in
a dose-dependent manner (not statistically significant)
(Supplementary Figure 1D). As Gli1 is a known target of
hedgehog signaling activation this response was used as a
positive control. This is consistent with previous work in a
chondrogenesis model using human bone marrow stromal/stem
cells (Handorf et al., 2015).
Ihh Deletion Does Not Rescue the
Gli3Xt−J/Xt−J Craniosynostosis
GLI transcription factors are effectors of HH signaling, with
GLI3 acting as a strong repressor of IHH signals in chondrocyte
differentiation with the developmental defects in endochondral
ossification observed in Ihh−/− mice being partially normalized
by the loss of Gli3 (Ihh−/−;Gli3Xt−J/Xt−J mice) (Koziel et al.,
2005). We considered an analogous role during osteoblast
development in the calvaria, and compared the calvarial
phenotypes of Ihh−/−, Gli3Xt−J/Xt−J and Ihh−/−;Gli3Xt−J/Xt−J
mutant mice, E16.5–18.5, to those of WT littermates
(Figure 3).
Calvarial bones of Ihh−/− mice were smaller than WT. The
size of the frontal and the interparietal bones was most affected,
the difference being the greatest at E16.5 [frontal bone 43%
smaller (p < 0.05), interparietal bone 33% smaller compared to
WT]. Concomitant with the reduced bone size was a widening
of all of the calvarial sutures [E16.5: posterior interfrontal suture
32% wider (p < 0.05), sagittal suture 43% wider, lambdoid
suture 45% wider. E18.5: lambdoid suture comparable to WT,
posterior interfrontal suture 47% wider (p < 0.05), sagittal
suture 71%wider (p< 0.05)] (Figures 3E–H,Q–T). The posterior
part of the frontal bone was reduced in height (in apical
direction) and the interfrontal suture was the widest posteriorly.
At E18.5, the overall length of Ihh−/− skull (nasal bones to the
occiput) was slightly reduced (7%, not significant). This was
in part due to the short cranial base (12% shorter, p < 0.05)
(Figures 3E,G).
Gli3Xt−J/Xt−J mutant mice showed very specific stage
and location differences in bone size and suture width
(Figures 3I–L,Q–T). Already at E16.5 25% of Gli3Xt−J/Xt−J mice
showed synostosis of the lambdoid suture. This was primarily
due to an increase in the size of the interparietal bone which
was enlarged from E16.5 onwards (Figure 3T) as opposed to a
generalized increase in the size of the parietal bone. At E16.5
the width of the posterior interfrontal suture in Gli3Xt−J/Xt−J
calvaria was significantly wider (26%, p < 0.05). However,
the surface area of the frontal bones was only 15% smaller.
This mismatch of the widened interfrontal suture in between
the near normally sized frontal bones, indicated that frontal
bone development was affected from an early stage and that
extrinsic factors, for example brain shape and size and may
affect frontal bone and interfrontal suture morphology. Later,
the size of the frontal bones relative to WT increased. This was
in part due to strong heterotopic ossification in the interfrontal
suture, which culminated in partial fusion of the suture at E18.5.
(Figure 3K). At every stage examined the width of sagittal suture
was significantly wider (p < 0.05) (51% wider compared to WT
at E16.5, 87% wider at E18.5), but the size of parietal bones was
not significantly smaller compared to WT (15% smaller at E16.5,
12% smaller at E18.5). This sagittal suture widening may be
caused also by extrinsic factors. At E16.5 and E18.5 overall length
of Gli3Xt−J/Xt−J mutant skull was comparable to WT samples
(Figures 3I–L).
In conclusion, Gli3Xt−J/Xt−J calvaria exhibited enlargement
of the interparietal bone and heterotopic interfrontal bones
with consequent interfrontal and lambdoid suture fusion. In
contrast, the same sutures were wider and the bones smaller
in Ihh−/− mice. These opposite differences led us to test
whether Gli3Xt−J/Xt−J phenotype could be rescued by deleting
Ihh. The craniosynostosis phenotype across the interfrontal
and lambdoid sutures in Gli3Xt−J/Xt−J mice was unaffected by
the loss of Ihh (Figures 3M–P), despite there being a small
normalization of interparietal size at E16.5 (not significant)
(Figure 3T). Thus, even in the absence of IHH ligand, Gli3
deletion is sufficient to drive precocious ossification of the suture
mesenchyme.
Unlike Ihh−/− Endochondral Bones,
Osteoblastogenesis In Ihh−/− Calvaria
Progresses Normally
Ihh−/− mice exhibit a severe disruption of endochondral
osteogenesis with a complete lack osteoblasts. In contrast Ihh−/−
mice do form calvarial bones (St-Jacques et al., 1999). Using
Runx2, Osterix (Osx, Sp7), Integrin binding sialoprotein (Ibsp),
and Bglap (Osteocalcin) as markers of increasing osteoblastic
maturity, we analyzed osteoblastogenesis in Ihh−/− embryonic
calvaria (Figure 4). We found that osteoblastogenesis progressed
normally even though the calvarial bones were small and thin,
and the sutures wide with marker expression reflecting this
phenotype (Figures 4E–H).
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FIGURE 2 | In the absence of Gli3, total RUNX2, RUNX2-II
and IHH are upregulated and RUNX2-I downregulated. (A) Protein samples from
(Continued)
FIGURE 2 | Gli3Xt−J/Xt−J calvarial osteoblasts in growth medium without
osteogenic supplements show upregulated levels of RUNX2-II and IHH, and
downregulated RUNX2-I, for 3 biological samples in each test group by six
separate western blot analysis, representative results are shown. (B,C) Results
are normalized against Actin antibody, and normalized values are shown with 1
representing the WT osteoblasts. (*p < 0.05) Error bars standard deviation.
De-repression of GLI3 in Ihh−/− Mice
Results in a Similar Calvarial Osteoblastic
Phenotype to Gli3Xt−J/Xt−J Mice
In Ihh−/− endochondral bones, we have previously shown that,
de-repression of GLI3R (Ihh−/−;Gli3Xt−J/Xt−J mice) is sufficient
to restore the RUNX2-positive osteoprogenitor population
(Koziel et al., 2005) but the additional action of GLI2A is required
to restore the progression of osteoblastogenesis to the RUNX2-
positive/Osterix-positive cell stage (Hilton et al., 2005). In
Ihh−/−;Gli3Xt−J/Xt−J calvaria the osteoblastic expression pattern
was similar to that inGli3Xt−J/Xt−J mice although the heterotopic
ossifications were less extensive (Figures 4M–P). Interestingly
Gli3Xt−J/Xt−J mice, which exhibit heterotopic ossifications in the
interfrontal suture, showed expression of immature osteoblasts
(Runx2 andOsx) extending across the full width of the suture and
more mature osteoblastic expression markers (Ibsp and Bglap)
were limited to isolated ossification islands (Figures 4I-L).
Ihh Is the Functional HH Ligand in Late
Embryonic Mouse Calvaria
Ptch1 and Gli1 are direct transcriptional targets of HH
signaling and both are upregulated by IHH (Lee et al., 2016).
In Gli3Xt−J/Xt−J mice, Ptch1 and Gli1 are expressed in the
developing calvarial bones and in the abnormal craniosynostotic
sutures. In Ihh−/− calvaria however, Ptch1 and Gli1 were absent,
indicating that no other Hh ligands are functional to compensate
for the lack of Ihh (Figures 5A–F).
Endochondral ossification defects observed in Ihh−/−
mice can be partially normalized by deletion of Gli3
(Ihh−/−;Gli3Xt−J/Xt−J mice). This rescue is accompanied
by a concomitant normalization of Ptch1 expression (Koziel
et al., 2005). We therefore decided to test whether Ptch1
and Gli1 are normalized in the developing calvaria of
Ihh−/−;Gli3Xt−J/Xt−J mice. However, similar to Ihh−/− calvaria,
Ptch1 and Gli1 expression were absent in Ihh−/−;Gli3Xt−J/Xt−J
mice (Figures 5G,H). This suggests that the mechanism of Ptch1
and HH signaling activation in the calvarial osteoprogenitors
differs compared to that in chondrocytes in the developing
growth plate.
Ihh Is Regulated by Runx2 in Calvarial
Osteoblasts and Calvarial Explants
In the developing growth plate, it has been shown that
Runx2 directly regulates Ihh expression in chondrocytes
(Yoshida et al., 2004). To test an analogous interaction
during intramembranous osteogenesis, we silenced Runx2 in
E15.5 primary calvarial osteoblasts by selective Runx2 siRNA.
Silencing was verified by western blot analysis showing
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FIGURE 3 | Craniosynostosis of Gli3Xt−J/Xt−J mice is IHH ligand independent. (A–P) Alizarin Red-S and Alcian blue stained WT and mutant embryos. (Q–T) Selected
suture width and bone area measurements. Compared to WT the calvarial bones of Ihh−/− mice (n = 8) are smaller and sutures are wider compared
(Continued)
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FIGURE 3 | (to the WT n = 20). Gli3Xt−J/Xt−J mice (n = 24) have heterotopic ossifications in the interfrontal suture. The interparietal bone is larger and the lambdoid
sutures are narrower with some samples already fused at E16.5. In contrast the sagittal suture is wider compared WT. Although the calvarial bone areas are reduced
at E16.5, deletion of Ihh in Ihh−/−;Gli3Xt−J/Xt−J (DKO) (n = 6) mice does not prevent the lambdoid sutures fusing (arrows) and heterotopic bones forming in the
interfrontal suture (arrowheads) by E18.5. f, frontal bone; ip, interparietal bone; is, interfrontal suture; ls, lambdoid suture; p, parietal bone; ss, sagittal suture; DKO,
double knockout (Ihh−/−;Gli3Xt−J/Xt−J ). (*, p < 0.1, **, p < 0.01 compared to WT). Error bars standard deviation. Scale bar 2mm.
FIGURE 4 | Osteoblasts differentiate in the absence of Ihh and Gli3. (A–P) E15.5 Frontal sections. Runx2, Osterix (Osx), Bglap (Osteocalcin) and Integrin binding
sialoprotein (Ibsp) are all expressed in the WT frontal bones, shown by in situ hybridization (A–D arrows). All markers are also expressed in the Ihh−/− frontal bones,
but the interfrontal suture is wider (E–H). In Gli3Xt−J/Xt−J (I–L) and Ihh−/−;Gli3Xt−J/Xt−J (M–P) calvaria Runx2, Osx, Bglap and Ibsp are expressed in the frontal
bones, but expression also extends to the interfrontal suture (arrowheads). b, brain; e, eye; f, frontal bone; is, interfrontal suture; s, skin. Scale bar 500µm.
that Runx2 protein was downregulated (Figures 6A,B). Ihh
protein levels were significantly (p < 0.001) downregulated
with Runx2 siRNA, when compared to negative controls
(Figures 6A,B). The regulation of Ihh by Runx2 was then
tested in embryonic calvarial organ culture with reduced
expression of Ihh observed adjacent to beads coated in
Runx2 siRNA, assayed by whole mount in situ hybridization
(Figure 6C).
DISCUSSION
Suture biogenesis involves the balance between the promotion
and suppression of osteogenesis. The correct location specificity
of the positive and negative osteo-inductive signals is important
so that aberrant bone formation does not take place. It is
not only important that the size and shape of the bones are
controlled and that ectopic bones do not form but also that
sutures stay patent to allow for continued brain and craniofacial
growth.
Here, we show how skull bone size and shape are tightly
controlled by hedgehog signaling in maintaining the required
balance of progenitor cells and functioning osteoblasts, with Gli3
having a pivotal role. Gli3R acts as an inhibitor of osteogenesis
in a location specific manner by repressing the osteo-inductive
key players, RUNX2-II and IHH. GLI3R can act to negatively
regulate RUNX2 or the function of RUNX2 via a least three
possible mechanisms: GLI3 inhibits RUNX2 by competitively
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FIGURE 5 | Ptch1 and Gli1 expression are not restored in Gli3Xt−J/Xt−J calvaria by deletion of Ihh. (A–H) Hh target genes Ptch1 and Gli1 are upregulated by Hh
ligand, E15.5 frontal sections are expressed in the developing WT frontal bone, shown by in situ hybridization (A,B, black arrows). However, in Ihh−/− frontal bones
Ptch1 and Gli1 are not expressed confirming that Ihh is the only Hh ligand expressed at this stage and that it activates Ptch1 and Gli1 (C,D, black arrows). In
Gli3Xt−J/Xt−J mice Ptch1 and Gli1 are expressed in the frontal bone (E,F black arrows), and in the interfrontal bones in the suture (E,F dotted black arrows). But in
Ihh−/−;Gli3Xt−J/Xt−J calvaria expression of both Ptch1 and Gli1 is absent (G,H black arrows). In Ihh−/− and Ihh−/−;Gli3Xt−J/Xt−J mice Ptch1 and Gli1 are
expressed in the skin where they are activated by Shh (C,D,G,H arrowheads). In Gli3Xt−J/Xt−J and Ihh−/−;Gli3Xt−J/Xt−J mice Gli1 is ectopically expressed in the
apical midline of the malformed cerebrum, intracranial to the interfrontal suture where it is activated by Shh (F,H blue arrow). b, brain; e, eye; f, frontal bone; is,
interfrontal suture; s, skin. Scale bar 1mm.
binding to the BGLAP (osteocalcin) promoter (Ohba et al., 2008;
Lopez-Rios et al., 2012); GLI3 inhibits BMP2-DLX5 activation of
RUNX2; and GLI3 upregulates Twist1 which directly represses
Runx2 (Bialek et al., 2004; Tanimoto et al., 2012). RUNX2-
I is down regulated in Gli3Xt−J/Xt−J sutures and RUNX2-II
upregulated. This is consistent with the expression of Runx2-
I by a more immature osteoprogenitor population than those
cells that express Runx2-II (Park et al., 2001; Tanimoto et al.,
2012).
The effects of Ihh deletion on endochondral ossification
are dramatic with long bones lacking osteoblasts (St-Jacques
et al., 1999). IHH promotes osteogenesis in the orthotopic
bone collar of endochondral bones through simultaneous GLI3
suppression and GLI2 activation (Hilton et al., 2005; Joeng
Frontiers in Physiology | www.frontiersin.org 10 December 2017 | Volume 8 | Article 1036
Veistinen et al. Calvarial Osteoblastic Cell Fate Specification
FIGURE 6 | RUNX2 regulates the expression of IHH. (A) Protein lysates from negative control siRNA (NC) and Runx2 siRNA treated calvarial osteoblasts analyzed by
western blotting with anti-RUNX2 and anti-IHH antibodies (triplicate). Runx2 siRNA downregulates RUNX2 and IHH. (B) Results are normalized against Actin antibody
staining, and normalized values are compared and shown as columns with standard error, with 1 representing the WT osteoblasts. Statistical values calculated using
Student’s t-test, with p < 0.001 considered highly significant (**, p < 0.001). (C) Mouse E15.5 calvaria cultured with Affi-gel blue agarose beads soaked in negative
control siRNA (NC) (n = 6) and anti-Runx2 siRNA (n = 32), and subsequently analyzed by Runx2 (C1, C2) and Ihh (C3, C4) in situ hybridization, with 28 out of 32
beads showing a reduction of Ihh (C4). Note Runx2 and Ihh expression adjacent to the negative control (NC) beads (C1, C3) but no Runx2 and Ihh expression
adjacent to the anti-Runx2 siRNA beads (C2, C4). scale bar 100µm.
and Long, 2009). Genetic expression of a constitutive Gli2
activator is insufficient to rescue the defective osteoblastic
differentiation in Ihh−/− mice. However, the additional
removal of Gli3 restores Runx2 and Osx expression (Joeng
and Long, 2009). The regulation of osteogenesis in the calvaria
differs from that in long bones as Ihh−/− calvaria express
Runx2 and Osx (Figures 4E,F). That said, IHH positively
regulates intramembranous osteogenesis with IHH duplications
resulting in an overexpression of IHH being associated with
craniosynostosis, and Ihh−/− mice exhibiting small calvarial
bones with expanded sutures (Figures 3E–H) (Klopocki et al.,
2011; Lenton et al., 2011). Despite us demonstrating that
IHH is the functional ligand for HH regulated osteogenesis in
the calvaria (Figures 5C,D), deletion of Ihh in Gli3Xt−J/Xt−J
calvaria was not sufficient to rescue the craniosynostosis
(Figures 3M–P). Despite the lack of IHH targets (Ptch1
and Gli1) in Ihh−/−;Gli3Xt−J/Xt−J mice (Figures 5G,H).
This highlights the repressive role of GLI3 and also that
Frontiers in Physiology | www.frontiersin.org 11 December 2017 | Volume 8 | Article 1036
Veistinen et al. Calvarial Osteoblastic Cell Fate Specification
FIGURE 7 | Tight regulation of calvarial osteogenesis by GLI3. (A) IHH inhibits the proteolytic truncation of GLI3 into its repressor form (Wang et al., 2000). GLI3R
inhibits RUNX2 by competitively binding to the BGLAP (osteocalcin) promoter (Ohba et al., 2008; Lopez-Rios et al., 2012); GLI3R inhibits BMP2-DLX5 activation of
RUNX2; and GLI3R upregulates Twist1 which directly represses Runx2 (Bialek et al., 2004; Tanimoto et al., 2012). IHH promotes GLI2A which permits the progression
of osteoblast differentiation from RUNX2-positive to RUNX2-positive/OSX-positive progenitors (Shimoyama et al., 2007). Our data suggests that RUNX2 may also
participate in the regulation IHH. Figure is adapted from (Joeng and Long, 2009), and (Long and Ornitz, 2013) (Joeng and Long, 2009; Long and Ornitz, 2013).
(B1) Osteogenesis in the normal suture. GLI3 primarily acts as an inhibitor of intramembranous ossification at the periphery of the bones calvarial bones. The
truncated repressor form of GLI3 (GLI3R) is the predominant isoform in the undifferentiated sutural mesenchyme (yellow) and at the peripheral edge of the osteogenic
condensation (blue). GLI3R restricts ossification and limits the proliferation rate of the mesenchymal osteoprogenitor cells by upregulating Twist1 (1). In midsutural
mesenchyme Runx2-I expression by relatively undifferentiated progenitors is high, while in the osteogenic condensation the Runx2 promoter is activated and both
Runx2 isoforms are upregulated. Ihh expression is highly localized within the osteogenic condensation possibly resulting in a short range activation of target genes,
including GLI2A. GLI3 repressor limits bone formation at the edge of the osteogenic condensation. In the osteogenic condensation RUNX2-I and RUNX2-II act in a
feedback loop by upregulating IHH (dashed line). Within the Ihh signaling domain (red) the truncation of GLI3FL to GLI3R does not occur and osteogenesis is
(Continued)
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FIGURE 7 | activated. Outside the IHH signaling domain, GLI3R is generated which inhibits osteogenesis and maintains suture patency. (B2) In Gli3Xt−J/Xt−J
calvaria, as GLI3R does not function, the tight regulation of osteogenesis is lost. This permits the expression domains of IHH and RUNX2 to expand and bone to form
across the suture. Key: GLI3 Full length (GLI3FL), GLI3 repressor (GLI3R), undifferentiated sutural mesenchyme (yellow), osteogenic condensation periphery (blue),
osteogenic condensation center (red), bone matrix (gray).
craniosynostosis is not just excessive osteogenesis but a
patterning defect.
Analysis of Ihh zebrafish mutants suggests that Ihh is involved
in osteoprogenitor recruitment and proliferation and ultimately
the regulation of dermal bone outgrowth and shape (Huycke
et al., 2012). Also, following local retroviral mis-expression of Ihh
in the developing chick frontal bone a developmentally later role
for Ihh has been suggested where it regulates the transition from
preosteoblastic progenitors to osteoblasts (Abzhanov et al., 2007).
Our results do not exclude the possibility that GLI3 has
other roles during calvarial development even prior to the
establishment of sutures. Inactivation of the BMP responsive
transcription factorsMsx1 andMsx2 from neural crest cells from
E9.5–E10.5 causes heterotopic ossification in the interfrontal
suture due to an alteration in the fate of the early migrating
neural crest cells (Roybal et al., 2010). A population of
calvarial mesenchymal cells arise from HH-responsive Gli1-
positive cells in the cephalic paraxial mesoderm and although
this transcriptional activation of Gli1 is transient, GLI3 may
have a role in controlling migration and patterning of these cells
(Deckelbaum et al., 2012).
During calvarial osteoblast differentiation Gli3 is expressed
prior to Ihh expression and then it functions as a repressor of HH
target genes. During limb patterning the situation is similar, as
GLI3 and dHand prepattern the limb bud before dHand activates
SHH signaling (te Welscher et al., 2002). Evidence also shows
that mouse limbs expressing only GLI3R have only one digit and
thus resemble Shh null allele mice. The primary mechanism by
which SHH patterns the anteriorposterior limb is by inhibiting
the GLI3R formation (Cao et al., 2013).
Two mouse models of craniosynostosis have been reported
with abnormal processing of GLI3 as an etiological factor. An
ENU-induced mouse model representing a hypomorphic allele
of Ptch1 has bilateral craniosynostosis of the lambdoid suture,
similar to Gli3Xt−J/Xt−J mice (Feng et al., 2013). This phenotype
is caused by a ligand-independent activation of HH signaling and
a decrease in GLI3R. Fuzzy is a regulator of cilia trafficking and
consequently HH signaling. Despite, Fuzzy null allele mice have
increased repression of GLI3R they also exhibit craniosynostosis,
all be it a different suture from that fused in Gli3Xt−J/Xt−J and
Ptch1 mutant mice. The coronal suture fusion seen in Fuz−/−
mice is associated with elevated fibroblast growth factor signaling
which is known to play a role in regulating suture patency (Tabler
et al., 2013).
We found that in Gli3Xt−J/Xt−J cells, RUNX2 and IHH
are elevated and silencing Runx2 decreases Ihh expression
(Figures 6A,B). This suggests that RUNX2 may control Ihh
expression during calvarial osteoblast differentiation, which
would be analogous to its role during chondrogenesis (Yoshida
et al., 2004). Ihh is expressed by progenitors in the osteogenic
fronts (Figures 1A,B) and it signals to the cells within
the osteogenic condensation to differentiate via a GLI2-
driven mechanism. Proteolytic processing of GLI3 into the
repressor isoform is inhibited in these cells allowing osteoblast
differentiation to proceed. Runx2 is upregulated and in turn
activates Ihh expression (Figures 2A–C).
CONCLUSIONS
The stepwise differentiation of osteoblasts from mesenchymal
progenitors through developmental stages characterized by the
expression of SOX9, RUNX2, and OSX is well described (Long
and Ornitz, 2013) (Figure 7A). IHH acts at 2 stages prior to
and post Runx2 positive cells (Joeng and Long, 2009). IHH
inhibits the post translational cleavage of GLI transcription
factors into truncated repressor forms (Wang et al., 2000).
Thus, when IHH is expressed GLI1 and −2 function as
activators of downstream targets to regulate osteogenesis. GLI1
regulates calvarial stem cells while GLI2 acts an activator which,
together with the simultaneous removal of GLI3R, allows the
progression of uncommitted RUNX2-positive osteoprogenitors
into committed RUNX2-positive/OSX-positive osteoprogenitors
(Shimoyama et al., 2007; Joeng and Long, 2009; Zhao et al., 2015).
We and others have previously shown that GLI3R regulates
calvarial osteogenesis by negatively regulating the action of
RUNX2.With RUNX2, GLI3R competitively binds to the BGLAP
(osteocalcin) promoter (Ohba et al., 2008; Lopez-Rios et al.,
2012). GLI3R inhibits the Bmp2-Dlx5 activation of Runx2 and
upregulates TWIST1 which directly represses RUNX2 (Bialek
et al., 2004; Tanimoto et al., 2012).
We show that IHH is the functional HH ligand in the late
embryonic mouse calvaria. But unlike Ihh−/− endochondral
bones, osteoblastogenesis in Ihh−/− calvaria progresses
normally. So IHH is not essential for calvarial osteoblastic
differentiation (St-Jacques et al., 1999). As IHH regulates the
conversion of full-length GLI3 into GLI3R, within the IHH
signaling domain the truncation of GLI3FL to GLI3R does not
occur and osteogenesis is activated. Outside the IHH signaling
domain, in immature mesenchymal progenitor cells, GLI3R
is generated which inhibits osteogenesis (Figure 7B). Here
we demonstrate a location specific regulatory role for GLI3R
within the suture which is independent of Ihh expression, as
IHH deletion does not rescue craniosynostosis exhibited by
Gli3Xt−J/Xt−J mice. We show that GLI3 represses the expression
of Runx2-II and Ihh, and elevates Runx2-I. And that IHH
is regulated by RUNX2 in calvarial osteoblasts and calvarial
explants. This raises the possibility of a regulatory feedback
circuit to control calvarial osteogenesis and suture patency.
While we have found some interesting results with regard to
intra-suture regulation of, particularly, the interfrontal suture,
we have not made extensive analyses of different sutures and at
multiple developmental stages. With these limitations in mind,
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caution is emphasized when extrapolating conclusions we make
from data mainly from the interfrontal suture to other sutures.
Taken together, we have presented evidence how GLI3R,
RUNX2 and IHH regulate the stage and location of osteoblast
differentiation in the calvarial sutures, which ultimately controls
skull bone patterning, shape and size.
AUTHOR CONTRIBUTIONS
Study design: LV, TM, MH, MT, AV, and DR, Data collection,
analysis, and interpretation: LV, TM, MH, MT, YK, DK, AV,
and DR, Drafting manuscript and final version approval: LV,
TM, MH, MT, YK, DK, AV, and DR, Responsibility for the
integrity of the data analysis: LV, TM, MH, MT, YK, DK, AV, and
DR.
FUNDING
This work was supported by Biocentrum Helsinki, The Research
Foundation of Helsinki University Hospital (TYH2015319),
Jusélius Foundation (4702957), Academy of Finland (257472)
and FINDOS.
ACKNOWLEDGMENTS
We are grateful to Airi Sinkko and Marjatta Kivekäs for excellent
technical assistance.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fphys.
2017.01036/full#supplementary-material
Supplementary Figure 1 | IHH does not affect the expression of Gli3 mRNA.
(A–D) Gli1,−2 and −3 expression levels in WT primary calvaria derived cells
analyzed by RT-qPCR at 1, 2, 6, and 24 h in response to application of 50, 100
and 250 ng/ml of recombinant mouse IHH. Exogenous IHH did not alter the
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up-regulation of Gli1 expression in a dose-dependent manner (not statistically
significant). As Gli1 is a known target of hedgehog signaling activation this
response was seen as a positive control.
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